Global Influenza diagnostics Market is valued at USD 1.91 billion in 2016 is anticipated to grow USD 3.6 billion with the compounded annual growth of 6.4% over the forecast period 2017-2025.

New York 5 July 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Influenza diagnostics industry is poised to raise USD 3.6 billion by 2025. . Influenza, which is commonly called the flu is an infectious disease of the upper respiratory system caused by the influenza virus. The seasonal influenza virus has three types, namely influenza B, influenza A, and influenza C that are differentiated on the basis of two major surface proteins namely, hemagglutinin (HA) and neuraminidase (NA). Various serotypes are seen based on differences in these surface proteins that determine the antibody response to the viruses.

 To view the summary or to request a sample copy of this report, please click the link mentioned below:

Global Influenza diagnostics Market Size study By Test Type (RIDT, RT-PCR, Cell Culture), By End-use (Hospitals, Laboratories, POCT) and by Regional Forecasts 2017-2025

The industry seems to be fairly competitive. Some of the leading market players include 3 AM Healthcare, Alere, meridian bioscience, Inc., Quidel Corporation, and so on. Other market players discussed in the report include Roche diagnostics corporation, SA Scientific, Thermo Fisher Scientific Inc. New product launches, acquisitions, and mergers are some of the strategies adopted by the key manufacturers. Additionally, the fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.

Key findings of the study:

  • Increasing number of individuals being susceptible to the disease, the demand for influenza diagnostics products has been rising fueling market growth.
  • Rising geriatric population, growing government initiatives to counter influenza will increase the growth of this market.
  • Increasing prevalence of chronic diseases such as diabetes, heart and blood disorders, and the emergence of technologically advanced influenza diagnostic tests also increase the market growth.

Bizwit Research & Consulting LLP has considered the following segments for the study:


By Test type:

  • RIDT
  • RT-PCR
  • Cell culture

By End Use:

  • Hospitals
  • Laboratories
  • POCT

Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Rest of the World

To get a sample of this report or to purchase a copy of the study, you can directly contact us. Or mail to us at

how can we help you?

For any specific query or to receive regular updates of our latest titles fill the details on the contact form or in the subscription box down below. Trust us, we hate spams too. You will only get the regular updates and quality contents.